Proton vs. traditional radiation therapy significantly improves survival in head and neck cancers, MD Anderson-led study finds

Sylvester-led study focuses on rate of failure in head and neck cancer trials

Researchers from Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine, and collaborators analyzed 692 clinical trials launched between 2000 and 2024.

January 23, 2026

Vol.52 No.03

Clinical Roundup

Mutation predicts chemoresistance and better responses to immunotherapy in advanced bladder cancer, MD Anderson study finds

Researchers at The University of Texas MD Anderson Cancer Center have determined that mutations in the KDM6A gene—common in advanced bladder cancer—may serve as a predictive biomarker to determine which patients are less likely to benefit from standard chemotherapy but may respond better to immunotherapy.

January 16, 2026

Vol.52 No.02

Drugs & Targets

SOPHiA GENETICS partners with MD Anderson on AI-driven precision oncology

SOPHiA GENETICS and The University of Texas MD Anderson Cancer Center have entered into a collaboration to accelerate data-driven cancer care through new tools that can accurately analyze, interpret, and translate diagnostic results into clinical practice.

January 09, 2026

Vol.52 No.1

In Brief

MD Anderson announces $2.5B philanthropic campaign

The University of Texas MD Anderson Cancer Center has launched a $2.5 billion comprehensive philanthropic campaign: Only Possible Here, The Campaign to End Cancer.

November 14, 2025

Vol.51 No.42

In Brief

MD Anderson’s Allison Institute, Crystal Cruises launch fundraising initiative

Crystal Cruises announced a fundraising initiative for the James P. Allison Institute at The University of Texas MD Anderson Cancer Center. Together, Crystal and MD Anderson will unite the worlds of travel and science in a collaboration designed to inspire, educate, and advance the global mission to end cancer.

November 14, 2025

Vol.51 No.42

In Brief

Kimberly Vanderhorst, Terri Lynn Dunn receive the Brown Foundation nursing award at MD Anderson

The University of Texas MD Anderson Cancer Center has awarded Kimberly Vanderhorst and Terri Lynn Dunn the 2025 Brown Foundation Award for Excellence in Oncology Nursing.

October 31, 2025

Vol.51 No.40

Proton vs. traditional radiation therapy significantly improves survival in head and neck cancers, MD Anderson-led study finds

YOU MAY BE INTERESTED IN

Sylvester-led study focuses on rate of failure in head and neck cancer trials

Mutation predicts chemoresistance and better responses to immunotherapy in advanced bladder cancer, MD Anderson study finds

SOPHiA GENETICS partners with MD Anderson on AI-driven precision oncology

MD Anderson announces $2.5B philanthropic campaign

MD Anderson’s Allison Institute, Crystal Cruises launch fundraising initiative

Kimberly Vanderhorst, Terri Lynn Dunn receive the Brown Foundation nursing award at MD Anderson

Renew today!

Subscriber content

Never miss an issue!

Login